Prevalence, Timing, and Impact of Early Recurrence of Atrial Tachyarrhythmias after Pulsed Field Ablation: A Secondary Analysis of the PULSED AF Trial

Atrial Fibrillation

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

N Engl J Med

Reichlin T, Kueffer T, Badertscher P, Jüni P, Knecht S, Thalmann G, Kozhuharov N, Krisai P, Jufer C, Maurhofer J, Heg D, Pereira TV, Mahfoud F, Servatius H, Tanner H, Kühne M, Roten L, Sticherling C, SINGLE SHOT CHAMPION Investigators

doi: 10.1056/NEJMoa2502280

Atrial Fibrillation

Incidence, Characteristics and Prognostic Significance of Early Recurrences Following Different Ablation Approaches for Persistent Atrial Fibrillation

Heart Rhythm

Virk SA, Chieng D, Segan L, Morton JB, Lee Mbchd G, Sparks P, McLellan AJ, Sugumar H, Prabhu S, Ling LH, Voskoboinik A, Pathak RK, Sterns LD, Ginks M, Sanders P, Kistler P, Kalman J

doi: 10.1016/j.hrthm.2024.12.031

Atrial Fibrillation

Complications associated with pulsed field ablation versus radiofrequency catheter ablation of atrial fibrillation

Heart Rhythm

Cho MS, Lee SR, Black-Maier E, Jackson KP, Friedman DJ, Pokorney SD, Loring Z, Febre J, Piccini JP

doi: 10.1016/j.hrthm.2024.10.063

Atrial Fibrillation

Inequities in Atrial Fibrillation Trials: An Analysis of Participant Race, Ethnicity, and Sex Over Time

Heart Rhythm

Lan RH, Paranjpe I, Saeed M, Perez MV

doi: 10.1016/j.hrthm.2024.06.052

Atrial Fibrillation

Pulsed-field vs. Cryoballoon vs. Radiofrequency ablation: outcomes after pulmonary vein isolation in patients with persistent atrial fibrillation

Heart Rhythm

Kueffer T, Stettler R, Maurhofer J, Madaffari A, Stefanova A, Iqbal SUR, Thalmann G, Kozhuharov NA, Galuszka O, Servatius H, Haeberlin A, Noti F, Tanner H, Roten L, Reichlin T

doi: 10.1016/j.hrthm.2024.04.045

Atrial Fibrillation

Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial

JAMA Cardiol

Zimerman A, Braunwald E, Steffel J, Van Mieghem NM, Palazzolo MG, Murphy SA, Chen CZL, Unverdorben M, Ruff CT, Antman EM, Giugliano RP

doi: 10.1001/jamacardio.2024.1793

Heart Failure

Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

JAMA Cardiol

Matsumoto S, Henderson AD, Jhund PS, Bauersachs J, Chioncel O, Claggett BL, Comin-Colet J, Desai AS, Filippatos G, Lam CSP, Pitt B, Scheerer MF, Lay-Flurrie J, Amarante F, Brinker M, Schou M, Senni M, Shah SJ, Voors AA, Zannad F, Zieroth S, Vaduganathan M, Solomon SD, McMurray JJV

doi: 10.1001/jamacardio.2025.0848

Atrial Fibrillation

Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

JAMA Cardiol

Alexander JH, Lydon EJ, Piccini JP, Viethen T, Oldgren J, Goodman SG, Steffel J, Russo AM, van Gelder IC, Ferdinand KC, Lopes RD, Mundl H, Benczur B, Gómez-Doblas JJ, Glikson M, Goudev A, Grove EL, Halvorsen S, Kiviniemi T, Martin AC, Sandhu RK, Vinereanu D, Rockhold FW, Caso V, Coppolecchia R, Patel MR

doi: 10.1001/jamacardio.2025.0277

Cardiac Arrest or Death

Effects of very early hyperoxemia on neurologic outcome after out-of-hospital cardiac arrest: A secondary analysis of the TTM-2 trial

Resuscitation

Sanfilippo F, Uryga A, Santonocito C, Jakobsen JC, Lilja G, Friberg H, Wendel-Garcia PD, Young PJ, Eastwood G, Chew MS, Unden J, Thomas M, Grejs AM, Wise MP, Lundin A, Hollenberg J, Hammond N, Saxena M, Martin A, Bánszky R, Taccone FS, Dankiewicz J, Nielsen N, Ebner F, BeloholaveK J, Hanggi M, Montagnani L, Patroniti N, Robba C, TTM-2 investigators

doi: 10.1016/j.resuscitation.2024.110460

Related content

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

Incidence, Characteristics and Prognostic Significance of Early Recurrences Following Different Ablation Approaches for Persistent Atrial Fibrillation

Complications associated with pulsed field ablation versus radiofrequency catheter ablation of atrial fibrillation

Inequities in Atrial Fibrillation Trials: An Analysis of Participant Race, Ethnicity, and Sex Over Time

Pulsed-field vs. Cryoballoon vs. Radiofrequency ablation: outcomes after pulmonary vein isolation in patients with persistent atrial fibrillation

Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial

Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

Effects of very early hyperoxemia on neurologic outcome after out-of-hospital cardiac arrest: A secondary analysis of the TTM-2 trial